Literature DB >> 18202875

Mutations that modulate receptor-hormone congruency as a cause of the primate GH receptor species specificity.

Sven Kurbel1, Danijela Gulam, Damir Kovacić, Ivan Mihaljević, Dario Faj.   

Abstract

Peptide hormones depend on reliable recognition by their receptors. Any mutation that compromises recognition of hormone and receptor molecules is dangerous, the carrier animal would not procreate and the mutation would be lost. Although, most of the hormones from one mammalian species are active when injected into another, the incompatibility of human GH receptor toward nonprimate GHs is a notable exception. It is reported that the coevolution of GH and GHR in primates includes two crucial steps (Mol. Biol. Evol. 18 (2001) 945). The first was mutation of GH His-->Asp at position 171 that happened before the split of Old world and New world monkeys. The second event was Leu-->Arg change at position 43 in the GH receptor molecule that happened in the ancestor of Old world monkeys. The proposed model is based on the possibility that certain mutations can modify the surface of one of interacting molecules to form a confined empty space, a niche in the otherwise congruent hormone/receptor interface. Altoough affinity between molecules is probably slightly reduced, recognition and function are not compromised in this special case. Further mutations of hormone and receptor molecules are allowed under the condition that they remain confined to the niche space. Mutations that do not compromise hormone function can be passed to offsprings. If the consequent mutation of one molecule change its shape to fill the niche space, further mutations without function loss will become less probable. Without the niche space, the phase of fast evolution is closed and both genes become conserved. In this setting, accumulated mutations before the niche closing mutation are the cause of species specificity. To become a dominant variety, carrier animals must possess survival advantage in comparison to the carriers of other less advantageous mutations.

Entities:  

Year:  2005        PMID: 18202875     DOI: 10.1016/j.thbio.2004.10.004

Source DB:  PubMed          Journal:  Theory Biosci        ISSN: 1431-7613            Impact factor:   1.919


  4 in total

1.  Variable evolutionary rates in the molecular evolution of mammalian growth hormones.

Authors:  M Wallis
Journal:  J Mol Evol       Date:  1994-06       Impact factor: 2.395

2.  Episodic evolution of growth hormone in primates and emergence of the species specificity of human growth hormone receptor.

Authors:  J C Liu; K D Makova; R M Adkins; S Gibson; W H Li
Journal:  Mol Biol Evol       Date:  2001-06       Impact factor: 16.240

3.  Growth hormone and insulin binding to human liver.

Authors:  D Carr; H G Friesen
Journal:  J Clin Endocrinol Metab       Date:  1976-03       Impact factor: 5.958

4.  Functional promiscuity of squirrel monkey growth hormone receptor toward both primate and nonprimate growth hormones.

Authors:  Soojin Yi; Bryan Bernat; Gábor Pál; Anthony Kossiakoff; Wen-Hsiung Li
Journal:  Mol Biol Evol       Date:  2002-07       Impact factor: 16.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.